Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion defect

Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion.

Published: 23 October 2025

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain losartan potassium/hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain risperidone tablets in error.

Pharmacists are advised to use caution and consider extra safeguards for these batches in robotic or automated dispensing system or stocking systems and should carry out manual dispensing and stocking, as appropriate. Pharmacy providers should also consider local assessments, in line with this notification and inform Relonchem Ltd of any stock that cannot be used in an automated dispensing system.

Further information, advice and details of the affected batches can be found on the MHRA website.